Outcome of Board Meeting of Laxmi Dental Limited held on Thursday, May 21, 2026 for approval of audited financial results (standalone and consolidated) for the quarter and financial year ....

Net loss reportedExceptional itemNegative operating cash flowRelated-party transactionsResults View source PDF Explain this filing

LAXMIDENTL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+19.0%Reaction day

₹209.50

prior close

₹236.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+18.9% vs market

Medical Equipment & Supplies peers, median of 9sector+1.2%+17.8% vs sector

On the reaction day the stock moved 18.9 pts more than Nifty Microcap 250 and 17.8 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+5.6

10m

+5.6

15m

+5.6

30m

+4.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+19.0+0.1+18.9+1.2+17.8

Next day

+16.0+1.7+14.3+1.3+14.8

+12.2+2.4+9.8+1.5+10.7

+16.2+2.4+13.8+1.3+14.9

+11.6+1.7+9.9-0.4+12.0

+10.3+0.6+9.7-3.2+13.4

+11.7+1.9+9.8-2.3+14.0

15d

+7.9+4.9+3.0-2.6+10.5

+8.6+8.9-0.3+0.7+7.8

+4.1+7.5-3.5+6.8-2.8

-7.1+13.6-20.7+4.1-11.1

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 9Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Laxmi Dental Limited reported standalone revenue growth of 21.8% to ₹2,060.37 million in FY26 from ₹1,691.57 million in FY25. However, standalone PAT declined 25% to ₹193.37 million from ₹257.75 million due to an exceptional charge of ₹51.56 million for gratuity provisions under new Labour Codes. Consolidated revenue grew 14.8% to ₹2,715.03 million with consolidated PAT from continuing operations at ₹264.30 million vs ₹253.75 million. The auditor issued an unmodified (clean) opinion. The company has a pending merger of its wholly-owned subsidiary Bizdent Devices Private Limited. IPO proceeds of ₹1,281.70 million remain partially unutilized with ₹546.63 million in fixed deposits.

Likely market impact

Standalone PAT decline of 25% and EPS drop from ₹4.92 to ₹3.52 signals margin pressure from the one-time labour code charge, though the underlying operational revenue growth remains healthy at ~20%. The significant negative operating cashflow of ₹-352.59 million warrants monitoring.